| Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra bmj 371, 2020 | 806 | 2020 |
| Neutralization of variant under investigation B. 1.617. 1 with sera of BBV152 vaccinees PD Yadav, GN Sapkal, P Abraham, R Ella, G Deshpande, DY Patil, ... Clinical Infectious Diseases 74 (2), 366-368, 2022 | 269 | 2022 |
| Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2 GN Sapkal, PD Yadav, R Ella, GR Deshpande, RR Sahay, N Gupta, ... Journal of Travel Medicine 28 (4), taab051, 2021 | 146 | 2021 |
| Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin PD Yadav, GN Sapkal, R Ella, RR Sahay, DA Nyayanit, DY Patil, ... Journal of Travel Medicine 28 (7), taab104, 2021 | 103 | 2021 |
| Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques PD Yadav, R Ella, S Kumar, DR Patil, S Mohandas, AM Shete, ... Nature communications 12 (1), 1386, 2021 | 95 | 2021 |
| Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients GR Deshpande, GN Sapkal, BN Tilekar, PD Yadav, Y Gurav, S Gaikwad, ... Indian Journal of Medical Research 152 (1-2), 82-87, 2020 | 77 | 2020 |
| Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG G Sapkal, A Shete-Aich, R Jain, PD Yadav, P Sarkale, R Lakra, ... Indian Journal of Medical Research 151 (5), 444-449, 2020 | 71 | 2020 |
| Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS-CoV-2 vaccine candidates in the Syrian hamster model S Mohandas, PD Yadav, A Shete-Aich, P Abraham, KM Vadrevu, ... IScience 24 (2), 2021 | 70 | 2021 |
| Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus endemic to Asia PD Yadav, B Malhotra, G Sapkal, DA Nyayanit, G Deshpande, N Gupta, ... Infection, Genetics and Evolution 69, 199-202, 2019 | 67 | 2019 |
| Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation B Ganneru, H Jogdand, VK Daram, D Das, NR Molugu, SD Prasad, ... Iscience 24 (4), 2021 | 60 | 2021 |
| Prevalence and assessment of clinical management of sexually transmitted infections among female sex workers in two cities of India A Das, P Prabhakar, P Narayanan, G Neilsen, T Wi, S Kumta, G Rao, ... Infectious diseases in obstetrics and gynecology 2011, 2011 | 60 | 2011 |
| Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum GN Sapkal, PD Yadav, R Ella, GR Deshpande, RR Sahay, N Gupta, ... BioRxiv, 2021.01. 26.426986, 2021 | 55 | 2021 |
| Neutralization potential of Covishield vaccinated individuals sera against B. 1.617. 1 PD Yadav, GN Sapkal, P Abraham, G Deshpande, DA Nyayanit, DY Patil, ... Clinical Infectious Diseases 74 (3), 558-559, 2022 | 47 | 2022 |
| An exploration of elevated HIV and STI risk among male sex workers from India P Narayanan, A Das, G Morineau, P Prabhakar, GR Deshpande, ... BMC public health 13, 1-9, 2013 | 44 | 2013 |
| Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India V Potdar, SS Cherian, GR Deshpande, PT Ullas, PD Yadav, ... Indian Journal of Medical Research 151 (2-3), 255-260, 2020 | 43 | 2020 |
| Genital ulcer disease in India: etiologies and performance of current syndrome guidelines P Prabhakar, P Narayanan, GR Deshpande, A Das, G Neilsen, ... Sexually transmitted diseases 39 (11), 906-910, 2012 | 42 | 2012 |
| Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals GN Sapkal, PD Yadav, RR Sahay, G Deshpande, N Gupta, DA Nyayanit, ... Journal of Travel Medicine 28 (7), taab119, 2021 | 38 | 2021 |
| Comparable neutralization of SARS-CoV-2 Delta AY. 1 and Delta with individuals sera vaccinated with BBV152 PD Yadav, RR Sahay, G Sapkal, D Nyayanit, AM Shete, G Deshpande, ... Journal of Travel Medicine 28 (8), taab154, 2021 | 32 | 2021 |
| Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern S Mohandas, PD Yadav, G Sapkal, AM Shete, G Deshpande, ... EBioMedicine 79, 2022 | 28 | 2022 |
| Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against alpha, Beta, Delta and omicron variants of concern GR Deshpande, PD Yadav, P Abraham, DA Nyayanit, GN Sapkal, ... Journal of Travel Medicine 29 (3), taac039, 2022 | 27 | 2022 |
